Pilot Neoadjuvant Trial with Combination of Lapatinib and Nab-Paclitaxel in HER2+Breast Cancer

被引：0
|
作者：
Kaklamani, V [1 ]
Uthe, R. [1 ]
Khan, S. [1 ]
Hansen, N. [1 ]
Bethke, K. [1 ]
Jeruss, J. [1 ]
Cianfrocca, M. [1 ]
Von Roenn, J. [1 ]
Rosen, S. [1 ]
Gradishar, W. [1 ]
机构：
[1] Northwestern Univ, Chicago, IL 60611 USA
来源：
CANCER RESEARCH | 2009年 / 69卷 / 24期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：568S / 568S
页数：1
相关论文
共 50 条
  • [11] Neoadjuvant nab-paclitaxel in breast cancer: who stands to benefit?
    Biganzoli, Laura
    McCartney, Amelia
    CHINESE CLINICAL ONCOLOGY, 2020, 9 (03)
  • [12] A randomized, controlled phase II trial of neoadjuvant ado-trastuzumab emtansine, lapatinib, and nab-paclitaxel versus trastuzumab, pertuzumab, and paclitaxel in HER2-positive breast cancer (TEAL study)
    Tejal A. Patel
    Joe E. Ensor
    Sarah L. Creamer
    Toniva Boone
    Angel A. Rodriguez
    Poly A. Niravath
    Jorge G. Darcourt
    Jane L. Meisel
    Xiaoxian Li
    Jing Zhao
    John G. Kuhn
    Roberto R. Rosato
    Wei Qian
    Anna Belcheva
    Mary R. Schwartz
    Virginia G. Kaklamani
    Jenny C. Chang
    Breast Cancer Research, 21
  • [13] A randomized, controlled phase II trial of neoadjuvant ado-trastuzumab emtansine, lapatinib, and nab-paclitaxel versus trastuzumab, pertuzumab, and paclitaxel in HER2-positive breast cancer (TEAL study)
    Patel, Tejal A.
    Ensor, Joe E.
    Creamer, Sarah L.
    Boone, Toniva
    Rodriguez, Angel A.
    Niravath, Poly A.
    Darcourt, Jorge G.
    Meisel, Jane L.
    Li, Xiaoxian
    Zhao, Jing
    Kuhn, John G.
    Rosato, Roberto R.
    Qian, Wei
    Belcheva, Anna
    Schwartz, Mary R.
    Kaklamani, Virginia G.
    Chang, Jenny C.
    BREAST CANCER RESEARCH, 2019, 21 (01)
  • [14] Phase Ib trial of trastuzumab emtansine (TE) in combination with lapatinib (L) plus nab-paclitaxel (A) in metastatic HER2-neu overexpressed breast cancer patients: STELA trial results
    Patel, Tejal
    Mejia, Jaime
    Rodriguez, Angel
    Chang, Jenny
    CANCER RESEARCH, 2015, 75
  • [15] Neoadjuvant pyrotinib plus trastuzumab and nab-paclitaxel for HER2-positive early or locally advanced breast cancer: an exploratory phase II trial
    Zhong, Xiaorong
    He, Ping
    Chen, Jie
    Yan, Xi
    Wei, Bin
    Zhang, Zhang
    Bu, Hong
    Li, Jing
    Tian, Tinglun
    Lv, Qing
    Wang, Xiaodong
    Li, Hongjiang
    Wang, Jing
    Huang, Juan
    Suo, Jiaojiao
    Liu, Xiaoxiao
    Zheng, Hong
    Luo, Ting
    GLAND SURGERY, 2022, 11 (01) : 216 - +
  • [16] Neoadjuvant nab-paclitaxel followed by FEC for operable breast cancer: KBC-SG 1103 trial
    Yamamoto, Y.
    Anan, K.
    Tanaka, M.
    Maeda, S.
    Ueo, H.
    Sagara, Y.
    Ohno, S.
    Iwase, H.
    Mitsuyama, S.
    Tamura, K.
    BREAST, 2015, 24 : S99 - S99
  • [17] Phase II Trial of Neoadjuvant Carboplatin and Nab-Paclitaxel in Patients with Triple-Negative Breast Cancer
    Yuan, Yuan
    Lee, Jin Sun
    Yost, Susan E.
    Li, Sierra Min
    Frankel, Paul H.
    Ruel, Christopher
    Schmolze, Daniel
    Robinson, Kim
    Tang, Aileen
    Martinez, Norma
    Stewart, Daphne
    Waisman, James
    Kruper, Laura
    Jones, Veronica
    Menicucci, Andrea
    Uygun, Sahra
    Yoder, Erin
    van der Baan, Bastiaan
    Yim, John H.
    Yeon, Christina
    Somlo, George
    Mortimer, Joanne
    ONCOLOGIST, 2021, 26 (03): : E382 - E393
  • [18] Adjuvant and neoadjuvant trastuzumab in combination with vinorelbine for HER2+breast cancer.
    Esfahani, Khashayar
    Ferrario, Cristiano
    Le, Philippe
    Panasci, Lawrence C.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [19] Study of neoadjuvant therapy with FEC followed by weekly nab-paclitaxel for breast cancer
    Nakagawa, S.
    Toh, U.
    Iwakuma, N.
    Mishima, M.
    Takahashi, R.
    Furukawa, M.
    Yamaguchi, M.
    Tanaka, M.
    Ogo, E.
    Akagi, Y.
    BREAST, 2015, 24 : S90 - S90
  • [20] Cardiotoxicity monitoring of pyrotinib in combination with nab-paclitaxel, doxorubicin, and cyclophosphamide in HER2-positive breast cancer: a single-armed clinical trial
    Wang, Wei
    Wang, Lu
    Chang, Jin-Yi
    Hu, Fen
    Yan, Jin-Yin
    Zhang, Juan
    Liang, Yong-Ping
    Zhang, Hui-Wen
    Wu, Hong-Peng
    Cai, Hai-Feng
    GLAND SURGERY, 2022, 11 (04) : 742 - 750
12345